XML 45 R32.htm IDEA: XBRL DOCUMENT v3.4.0.3
Business Segments (Tables)
12 Months Ended
Mar. 31, 2016
Segment Reporting [Abstract]  
Schedule of business segments information
Business segment information is summarized as follows:

 
Years ended March 31,
 
Quarter ended (transition period) March 31,
 
Year ended December 31,
 
2016
 
2015
 
2014
 
2013
Net sales to external customers:
 
 
 
 
 
 
 
UGG wholesale
$
918,102

 
$
903,926

 
$
83,271

 
$
818,377

Teva wholesale
121,239

 
116,931

 
45,283

 
109,334

Sanuk wholesale
90,719

 
102,690

 
28,793

 
94,420

Other brands wholesale
100,820

 
76,152

 
18,662

 
38,276

Direct-to-Consumer
644,317

 
617,358

 
118,707

 
496,211

 
$
1,875,197

 
$
1,817,057

 
$
294,716

 
$
1,556,618

Income (loss) from operations:
 
 
 
 
 
 
 
UGG wholesale
$
246,990

 
$
269,489

 
$
13,595

 
$
224,738

Teva wholesale
17,692

 
13,320

 
6,425

 
9,166

Sanuk wholesale
15,565

 
21,914

 
7,530

 
20,591

Other brands wholesale
(4,384
)
 
(9,838
)
 
(758
)
 
(9,807
)
Direct-to-Consumer
101,756

 
150,320

 
20,918

 
132,532

Unallocated overhead costs
(215,492
)
 
(220,786
)
 
(48,118
)
 
(169,323
)
 
$
162,127

 
$
224,419

 
$
(408
)
 
$
207,897

Depreciation and amortization:
 
 
 
 
 
 
 
UGG wholesale
$
2,107

 
$
5,029

 
$
137

 
$
641

Teva wholesale
54

 
94

 
33

 
641

Sanuk wholesale
6,556

 
6,969

 
1,769

 
7,761

Other brands wholesale
1,101

 
940

 
250

 
507

Direct-to-Consumer
18,931

 
21,088

 
5,209

 
21,861

Unallocated overhead costs
20,992

 
15,030

 
3,140

 
9,959

 
$
49,741

 
$
49,150

 
$
10,538

 
$
41,370

Capital expenditures:
 
 
 
 
 
 
 
UGG wholesale
$
1,458

 
$
246

 
$
119

 
$
313

Teva wholesale

 
51

 

 
63

Sanuk wholesale
881

 
487

 
2

 
91

Other brands wholesale
51

 
351

 
26

 
477

Direct-to-Consumer
18,445

 
19,128

 
3,557

 
35,669

Unallocated overhead costs
45,351

 
71,590

 
13,916

 
43,217

 
$
66,186

 
$
91,853

 
$
17,620

 
$
79,830

Total assets from reportable segments:
 
 
 
 
 
 
 
UGG wholesale
$
248,937

 
$
194,720

 
$
153,341

 
$
314,122

Teva wholesale
87,225

 
77,423

 
81,766

 
54,868

Sanuk wholesale
212,816

 
224,974

 
214,627

 
208,669

Other brands wholesale
65,072

 
53,634

 
41,281

 
34,315

Direct-to-Consumer
148,733

 
147,423

 
163,664

 
189,822

 
$
762,783

 
$
698,174

 
$
654,679

 
$
801,796

Schedule of reconciliations of total assets from reportable segments to the condensed consolidated balance sheets
Reconciliations of total assets from reportable segments to the consolidated balance sheets are as follows:

 
3/31/2016
 
3/31/2015
Total assets from reportable segments
$
762,783

 
$
698,174

Unallocated cash and cash equivalents
245,956

 
225,143

Unallocated deferred tax assets
20,636

 
29,083

Other unallocated corporate assets
248,693

 
217,533

Consolidated total assets
$
1,278,068

 
$
1,169,933